Skip to main content
RXRX filings

Corporate insider profile

Robert Hershberg Filing Activity

Latest reported as Corporate insider of RECURSION PHARMACEUTICALS, INC. (RXRX).

Purchase filings
0
Reported companies
3
Net open-market value
-$1,369,207.73
Latest transaction
Oct 6, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 6, 2026RECURSION PHARMACEUTICALS, INC. (RXRX)Corporate insiderSale25,000$5.00$125,000
Aug 18, 2026Adaptive Biotechnologies Corp (ADPT)Corporate insiderSale30,664$24.40$748,208
Jul 7, 2026AtaiBeckley Inc. (ATAI)DirectorSale100,000$4.96$496,000